Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by Dibah42on Apr 26, 2015 9:44pm
168 Views
Post# 23666101

Merger possibilities

Merger possibilities
"Second, management is also actively exploring potential strategic merger possibilities for its business with companies whose own assets combined with those of DiagnoCure might lead to a strengthening of market position for both partners.
Read more at https://www.stockhouse.com/news/press-releases/2015/04/23/diagnocure-provides-business-up-date#jquVCp1I77vHL7s2.99"

So which companies are we talking about?  What do we bring to them?  What exactly is our NAV now?  Cash, tax credits, patents?  What do they bring to us?
And why is TA still buying?  Are we looking at a shell co. tax loss merger?

<< Previous
Bullboard Posts
Next >>